(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -6.52%28.96B | -7.06%20.07B | -5.19%10.15B | 5.49%33.94B | 6.42%30.98B | 12.03%21.59B | 16.27%10.71B | 6.65%32.17B | 8.73%29.11B | 5.37%19.27B |
Operating income | -6.52%28.96B | -7.06%20.07B | -5.19%10.15B | 5.49%33.94B | 6.42%30.98B | 12.03%21.59B | 16.27%10.71B | 6.65%32.17B | 8.73%29.11B | 5.37%19.27B |
Operating expenses | 9.67%-16.87B | 10.72%-11.72B | 8.46%-6.05B | -2.46%-20.82B | -3.56%-18.67B | -10.02%-13.13B | -15.39%-6.6B | -6.43%-20.32B | -8.63%-18.03B | -5.02%-11.93B |
Gross profit | -1.73%12.09B | -1.37%8.35B | 0.06%4.1B | 10.68%13.12B | 11.07%12.31B | 15.30%8.47B | 17.71%4.1B | 7.02%11.85B | 8.91%11.08B | 5.93%7.34B |
Selling expenses | 1.79%-3.42B | 9.16%-2.17B | 12.16%-1.3B | -12.12%-4.71B | -8.04%-3.48B | -12.31%-2.39B | -13.38%-1.48B | -2.51%-4.2B | -7.69%-3.22B | 1.36%-2.13B |
Administrative expenses | 8.31%-938.92M | -1.76%-666.5M | -7.89%-344.83M | -3.10%-1.52B | 6.00%-1.02B | 7.27%-654.98M | 9.98%-319.62M | 12.95%-1.47B | 3.78%-1.09B | 0.74%-706.31M |
Research and development expenses | -60.64%-56.74M | -32.70%-29.41M | -66.70%-17.83M | -59.86%-100.64M | -16.93%-35.32M | -30.34%-22.16M | -84.37%-10.7M | -103.80%-62.95M | -124.85%-30.21M | -106.12%-17M |
Profit from asset sales | -44.47%11.26M | -101.71%-189.51K | -100.32%-32.08K | 1,976.25%178.58M | 267.35%20.28M | -46.59%11.09M | 0.79%9.92M | -101.98%-9.52M | 88.43%-12.12M | 94.95%20.77M |
Revaluation surplus | -9.89%148.44M | 7.64%137.22M | -12.01%54.87M | 40.10%230.26M | 2.34%164.73M | 14.96%127.48M | 13.16%62.36M | -35.15%164.35M | -21.01%160.97M | -15.01%110.89M |
-Changes in the fair value of other assets | -9.89%148.44M | 7.64%137.22M | -12.01%54.87M | 40.10%230.26M | 2.34%164.73M | 14.96%127.48M | 13.16%62.36M | -35.15%164.35M | -21.01%160.97M | -15.01%110.89M |
Impairment and provision | -186.82%-2.75M | -492.54%-2.83M | -984.70%-628K | -548.63%-97.16M | -108.81%-960.49K | -156.38%-477.76K | -112.13%-57.9K | 92.57%-14.98M | 750.06%10.9M | 149.25%847.38K |
-Other impairment is provision | -186.82%-2.75M | -492.54%-2.83M | -984.70%-628K | -548.63%-97.16M | -108.81%-960.49K | -156.38%-477.76K | -112.13%-57.9K | 92.57%-14.98M | 750.06%10.9M | 149.25%847.38K |
Special items of operating profit | 13.75%461.54M | 32.24%347.44M | 5.05%129.76M | -21.04%563.16M | -30.24%405.76M | -26.05%262.74M | -14.06%123.51M | -3.88%713.18M | 1.04%581.67M | 26.24%355.27M |
Operating profit | 0.65%6.29B | 5.52%4.62B | 8.41%2.02B | 15.27%5.28B | 15.56%6.25B | 19.65%4.38B | 27.25%1.86B | 8.75%4.58B | 14.66%5.41B | 16.33%3.66B |
Financing cost | 28.97%433.97M | 30.42%291M | 38.09%141.21M | 8.63%457.12M | 5.44%336.5M | 20.33%223.13M | 65.31%102.26M | 73.04%420.81M | 64.49%319.14M | 36.93%185.43M |
Special items of earning before tax | -42.22%3.28M | -230.72%-2.41M | -62.50%1.07M | 83.69%9.58M | -27.27%5.67M | 934.85%1.84M | 313.51%2.85M | -78.28%5.22M | -64.67%7.79M | -102.35%-220.76K |
Earning before tax | 2.06%6.73B | 6.64%4.91B | 9.86%2.16B | 14.79%5.75B | 14.94%6.6B | 19.74%4.6B | 29.10%1.96B | 11.77%5.01B | 16.27%5.74B | 16.84%3.85B |
Tax | -0.27%-1.6B | -5.85%-1.19B | -8.85%-533.81M | -16.38%-1.4B | -16.34%-1.6B | -19.86%-1.12B | -33.02%-490.42M | 1.74%-1.2B | -12.65%-1.37B | -16.52%-936.79M |
After-tax profit from continuing operations | 2.63%5.13B | 6.89%3.72B | 10.19%1.62B | 14.28%4.35B | 14.49%5B | 19.70%3.48B | 27.84%1.47B | 16.84%3.8B | 17.45%4.37B | 16.95%2.91B |
Earning after tax | 2.63%5.13B | 6.89%3.72B | 10.19%1.62B | 14.28%4.35B | 14.49%5B | 19.70%3.48B | 27.84%1.47B | 16.84%3.8B | 17.45%4.37B | 16.95%2.91B |
Minority profit | 53.83%140.3M | 42.87%79.48M | 18.82%26.24M | -14.61%80.35M | -7.95%91.2M | -1.05%55.63M | -15.84%22.08M | -6.64%94.09M | -7.05%99.08M | -21.20%56.22M |
Profit attributable to shareholders | 1.67%4.99B | 6.31%3.64B | 10.06%1.6B | 15.02%4.27B | 15.02%4.91B | 20.11%3.43B | 28.86%1.45B | 17.59%3.71B | 18.17%4.27B | 18.07%2.85B |
Basic earnings per share | 1.52%3.667 | 6.20%2.672 | 9.71%1.175 | 14.73%3.139 | 14.70%3.612 | 19.81%2.516 | 28.42%1.071 | 17.53%2.736 | 18.16%3.149 | 17.98%2.1 |
Diluted earnings per share | 1.58%3.66 | 6.24%2.672 | 9.94%1.172 | 14.81%3.132 | 14.82%3.603 | 19.82%2.515 | 28.59%1.066 | 17.38%2.728 | 17.97%3.138 | 17.92%2.099 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data